StockNews.AISignal intelligence
Integer Holdings Corporation · NYSE · Healthcare
Browse public ITGR signals with their source context and measured market impact. Open any signal for its permanent analysis page.
Private equity firm KKR is nearing a takeover of Integer Holdings, per a Wall Street Journal report. No terms were disclosed, and the deal remains uncertain. If confirmed, an acquisition would likely push ITGR higher on a premium and re-rate the stock in anticipation of strategic value and potential synergies, though execution risk and financing details remain key near-term questions.
View signal analysisITGR reported Q3 earnings of $1.79, beating estimates of $1.68. Sales increased by 8%, with adjusted EPS growth of 25% year-over-year. FY2025 EPS guidance narrowed; sales forecast reduced slightly. Analysts downgraded ITGR, lowering price targets significantly after earnings. Shares fell 3.2% to $71.49 following the reports and downgrades.
View signal analysisITGR shares fell 32% on disappointing financial projections for 2025. Despite earnings meeting expectations, new product uptake was slow. ITGR shows moderate valuation despite risks and recent downturn. Growth rate of 12% exceeds S&P 500's 5.4% over the past three years. Long-term investors may find substantial returns in ITGR despite volatility.
View signal analysisQuarterly earnings expected at $1.24 per share, up 8.8% year-over-year. Forecasted revenue of $438.15 million, marking a 9.5% increase year-over-year. No revisions in consensus EPS estimates signal stability in analysts' forecasts. Negative projections for 'Sales- Non-Medical' down by 22.1% from last year. Analysts predict mixed performance in medical sales across various segments.
View signal analysis- ITGR delivered EPS of $1.14 in Q1 2024, beating estimates by 1.8%. - Revenues reached $414.8 million, up 9.5% YoY, driven by Medical sales. - Margin expanded, with adjusted EPS projected to rise 7-16% for 2024. - Price Impact Rating: Bullish - Impact Horizon Rating: Long-term - Type: Corporate Developments
View signal analysis